Market Closed -
Other stock markets
|
Pre-market 12:18:35 | |||
130.4 USD | +2.20% | 130.8 | +0.29% |
05-07 | CytomX Therapeutics, Inc. Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with Keytruda® (pembrolizumab) | CI |
05-02 | Merck: encouraging results in gastric cancer | CF |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Trading Ideas